Interestingly, while no significant differences in T cell abundance were observed in shC vs. shTAZ tumours (Fig. S2h,j), TAZ‐KO tumours analysed 2 weeks post‐injection displayed decreased abundance of infiltrating T cells (CD3+) relative to their WT counterparts (Fig. 3C,D). The gene discussed is WWTR1; the disease is neoplasm.